Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36002650e924d3edaec88b4324ca7e83 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C291-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C291-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
filingDate |
2009-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4da2cdf3f8b0f7dc8053bda1572e30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25dc1a94845e92736e8b26b3e1a60401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d55e6045bbcb9cb8ca68bbb1e627eed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb56f9926e324dd55e55f06de4b631a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2830cbb8d418e5e3b314d3dbbfc45102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07599f681c7cc183992dc06d99a50d1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7207c2fcd5770e11a2d61fc08c7fb50c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6cfef4bbf10232cc121303c7f905ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22b9ac505b36858de6225c607e817d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a3089940d5b69a0e85055373239514 |
publicationDate |
2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-102099330-B |
titleOfInvention |
Nitric oxide donating prostamides |
abstract |
Nitroderivatives of prostaglandins having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension. |
priorityDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |